210 related articles for article (PubMed ID: 25060702)
1. A Smad3 and TTF-1/NKX2-1 complex regulates Smad4-independent gene expression.
Isogaya K; Koinuma D; Tsutsumi S; Saito RA; Miyazawa K; Aburatani H; Miyazono K
Cell Res; 2014 Aug; 24(8):994-1008. PubMed ID: 25060702
[TBL] [Abstract][Full Text] [Related]
2. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.
Levy L; Howell M; Das D; Harkin S; Episkopou V; Hill CS
Mol Cell Biol; 2007 Sep; 27(17):6068-83. PubMed ID: 17591695
[TBL] [Abstract][Full Text] [Related]
3. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
4. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
[TBL] [Abstract][Full Text] [Related]
5. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
[TBL] [Abstract][Full Text] [Related]
6. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Tong X; Wang S; Lei Z; Li C; Zhang C; Su Z; Liu X; Zhao J; Zhang HT
Oncogene; 2020 Apr; 39(14):2890-2904. PubMed ID: 32029901
[TBL] [Abstract][Full Text] [Related]
7. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.
Xue J; Lin X; Chiu WT; Chen YH; Yu G; Liu M; Feng XH; Sawaya R; Medema RH; Hung MC; Huang S
J Clin Invest; 2014 Feb; 124(2):564-79. PubMed ID: 24382352
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
[TBL] [Abstract][Full Text] [Related]
9. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition.
Vincent T; Neve EP; Johnson JR; Kukalev A; Rojo F; Albanell J; Pietras K; Virtanen I; Philipson L; Leopold PL; Crystal RG; de Herreros AG; Moustakas A; Pettersson RF; Fuxe J
Nat Cell Biol; 2009 Aug; 11(8):943-50. PubMed ID: 19597490
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.
Lai CF; Feng X; Nishimura R; Teitelbaum SL; Avioli LV; Ross FP; Cheng SL
J Biol Chem; 2000 Nov; 275(46):36400-6. PubMed ID: 10964912
[TBL] [Abstract][Full Text] [Related]
12. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes.
Qureshi HY; Ricci G; Zafarullah M
Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A.
Bourgeois B; Gilquin B; Tellier-Lebègue C; Östlund C; Wu W; Pérez J; El Hage P; Lallemand F; Worman HJ; Zinn-Justin S
Sci Signal; 2013 Jun; 6(280):ra49. PubMed ID: 23779087
[TBL] [Abstract][Full Text] [Related]
14. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
15. BCL6 represses Smad signaling in transforming growth factor-beta resistance.
Wang D; Long J; Dai F; Liang M; Feng XH; Lin X
Cancer Res; 2008 Feb; 68(3):783-9. PubMed ID: 18245479
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
[No Abstract] [Full Text] [Related]
17. Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
Chen HB; Rud JG; Lin K; Xu L
J Biol Chem; 2005 Jun; 280(22):21329-36. PubMed ID: 15799969
[TBL] [Abstract][Full Text] [Related]
18. The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity.
Li X; Thyssen G; Beliakoff J; Sun Z
J Biol Chem; 2006 Aug; 281(33):23748-56. PubMed ID: 16777850
[TBL] [Abstract][Full Text] [Related]
19. Smad2 and Smad3 cooperate and antagonize simultaneously in vertebrate neurogenesis.
Míguez DG; Gil-Guiñón E; Pons S; Martí E
J Cell Sci; 2013 Dec; 126(Pt 23):5335-43. PubMed ID: 24105267
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
